Replies to post #73674 on Cytodyn Inc (CYDY)

[Venture_Cap]

That “pass” took a hit when they declined the combo to make Remdesivir look good.

Now, they have to play the FDA slow game and prove through clinical. They also have to have a solid media ground game to garner public support based on Eind and early clinical results.

External pressure on the Feds is key.

[ombowstring]

And if the Feds choose a drug to be used in combination with Remdesivir, I'd bet it'll be a Big Pharma drug. I've heard baricitimab - Olumiant manufactured by Eli Lilly; Actemra, Genentech-Roche, is also a possibility. We (CytoDyn) will have to break through on the merits of leronlimab, which is a distinct possibility based on anecdotal and clinical successes.

BP buys influence in Washington. The system is rigged. We haven't been lobbying, paying off Fauci and others with the power to make decisions.

[Irishvox]

Grip for a number of years I’ve enjoyed and sometimes disagreed with your posts on this board, curious what is your background/line of work is especially as it relates to “the game”? And by the way I was right on your poll with respect to the 27th being the date of the BLA filing so I will take that lagavulin with one whiskey cube!